Application 201380
- Type
- ANDA
- Sponsor
- MACLEODS PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 10MG BASE | No | No |
| 003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201380-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-04-13 | |
| A201380-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-04-13 | |
| A201380-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2026-02-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201380-001 | AB |
| A201380-002 | AB |
| A201380-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-04-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-04-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201380-003 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2026-02-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-04-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-04-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201380-003 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2026-02-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2012-04-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2012-04-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A201380-001 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2012-04-13 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A201380-002 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2012-04-13 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A201380-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201380-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201380-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A201380-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201380-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201380-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A201380-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201380-002 | AB | 1 | 011fe1cb6892… |
| 2019-12-13 00:20 UTC | 2019-12 | A201380-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201380-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A201380-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A201380-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A201380-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A201380-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A201380-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A201380-002 | AB | 1 | ea99ee380514… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201380-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201380-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201380-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 132c078d-7d31-a6f2-e063-6294a90af095 | 2024-03-08 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 52daa759-3327-461a-8cfc-3c6253df91ec | 2024-03-05 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Teva Pharmaceuticals, Inc. | 47edc328-2444-4ca1-a5c1-7c83141e105c | 2024-03-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | 498a9b21-34b9-4373-930b-5ed43201a345 | 2024-01-09 | Warnings, Adverse reactions | Amlodipine besylate AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Bryant Ranch Prepack | e8958997-f098-44ce-8c21-b7064d1a962e | 2024-01-09 | Warnings, Adverse reactions | Amlodipine besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 5c50c3fe-afe5-459e-95c0-c9af4cbb6909 | 2023-11-13 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 4512feee-a09d-4244-bc03-c43193e53a0e | 2023-09-20 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | d830173d-7676-4490-ab3d-d3515df9ad2e | 2023-09-07 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 5dfcba1f-91c4-4ca5-8a98-fc4fdb2f7ee1 | 2023-09-07 | Warnings, Adverse reactions | Amlodipine besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | ced6d26e-8c54-4808-88b6-446344f4acd0 | 2023-06-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 186b6149-9610-4380-9bf2-941646069276 | 2023-05-04 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | b597d1e1-aba1-4272-bed7-4c95e8150d58 | 2023-04-19 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Exelan Pharmaceuticals, Inc. | efd9eda5-f497-45a3-ae13-dee729add999 | 2023-03-23 | Warnings, Adverse reactions | Amlodipine besylate AMLODIPINE BESYLATE |
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Unichem Pharmaceuticals (USA), Inc. | a516b336-8f60-4b86-8921-c7d6c07629f2 | 2022-12-05 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | f3482709-c5c3-4bd0-8067-ad57f31bb525 | 2022-10-18 | Warnings, Adverse reactions | amlodipine besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 445d1274-7249-476b-ad90-ff93aee56f6d | 2022-06-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 5f3ac64c-6e33-40c1-9b8e-dc0c8dd7e8d6 | 2022-04-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine besylate | AMLODIPINE BESYLATE | Exelan Pharmaceuticals, Inc. | 1a24433f-4464-4c6d-9456-ed1ce38e8ec4 | 2022-03-12 | Warnings, Adverse reactions | Amlodipine besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | c2c51ec3-ffb0-4240-b048-a8e424775a76 | 2021-08-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.